“…Dendrimers, with their highly branched structures, enable precise targeting of ligands to tumour sites [ 36 ], while nanocrystals enhance drug solubility, stability, and cellular uptake, thereby enhancing tumour delivery [ 37 ]. Nanogels, formed from cross-linked polymer networks, provide a controlled release and targeted drug delivery [ 38 ], while quantum dots and semiconductor nanoparticles offer unique optical properties for imaging and targeted therapy [ 39 , 40 ]. These nanoparticles vary in size, shape, biocompatibility, and selectivity [ 41 , 42 ], with most falling within the clinical range of 3 to 200 nm in diameter [ 42 ].…”